Results 1 -
4
of
4
for
CAPLACIZUMAB
- Caplacizumab-yhdp injection is used to treat acquired thrombotic thrombocytopenic purpura (aTTP; a disorder in which the ... combination with plasma exchange therapy and immunosuppressant medications. Caplacizumab-yhdp is in a class of medications called ...
- Blood Clots/Specifics ... Blood Clots ... Platelet Disorders/Specifics ... Platelet Disorders ... National Heart, Lung, and Blood Institute ... Thrombotic thrombocytopenic purpura, ...
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
(National Library of Medicine) (National Institute of Diabetes and Digestive and Kidney Diseases) Medicines/Statistics and Research ... Medicines ... Liver Diseases/Statistics and Research ... Liver Diseases ... National Library of Medicine ... National Institute of Diabetes ... - Breastfeeding/Statistics and Research ... Breastfeeding ... National Library of Medicine ... From the National Institutes of Health ... The LactMed® database contains information ...
